REACT – REAl Care for AsThma - A disease study to identify patients with severe uncontrolled asthma - REACT-Asthma

Study identifier:D3250R00116

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

REACT – REAl Care for AsThma A disease study to identify patients with severe uncontrolled asthma using EMR pre-screening and AIRQ® score documentation over 12 months, including patient-documented OCS use with the AIRQ®-Active application

Medical condition

ASTHMA, BRONCHIAL

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1650

Study type

Observational

Age

18 Years - 120 Years

Date

Study Start Date: 15 Mar 2024
Estimated Primary Completion Date: 31 Jan 2026
Estimated Study Completion Date: 31 Jan 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria